Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
36 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Recursion Pharmaceuticals, Inc.’s names, not what it holds today.
Patents granted
36
35 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
9
Against 9 in 2024 and 5 in 2023
Applications published
59
25 of them in 2025
Names they are printed under
6
its own name, a subsidiary
By yearGrantedApplications published
'12'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Computer technology20
Medical technology4
Other special machines2
Pharmaceuticals2
Measurement1
Organic fine chemistry1
Digital communication1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
Recursion Pharmaceuticals, Inc. its own name
US, as the owner printed on each patent
16 publishedRecursion Pharmaceuticals, Inc. its own name
named as the applicant on its applications, in US
35 publishedEXSCIENTIA AI LIMITED a subsidiary
named as the applicant on its applications, in GB
5 publishedEXSCIENTIA LTD. a subsidiary
GB, as the owner printed on each patent
2 publishedExscientia AI Limited a subsidiary
GB, as the owner printed on each patent
1 publishedRe Ventures I, LLC a subsidiary
US, as the owner printed on each patent
0 publishedNames not counted (2)
Cyclica Inc.
Most of its patents print CA; this name counts in US. 0 granted and 5 published under it are not counted.
Cyclica Inc.
Most of its patents print CA; this name counts in US. 2 granted and 3 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 9, 2025 | 12,494,266 | Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictions | Computer technology | Recursion Pharmaceuticals, Inc. |
| Nov 4, 2025 | 12,462,903 | Utilizing compound-protein machine learning representations to generate bioactivity predictions | Computer technology | Recursion Pharmaceuticals, Inc. |
| Nov 4, 2025 | 12,462,899 | Utilizing compound-protein machine learning representations to generate bioactivity predictions | Computer technology | Recursion Pharmaceuticals, Inc. |
| Nov 4, 2025 | 12,461,091 | Systems and methods for discriminating effects on targets | Computer technology | Recursion Pharmaceuticals, Inc. |
| Aug 19, 2025 | 12,395,408 | Orchestration interface system for coordinating complex compound discovery pipelines across computer networks | Digital communication | Recursion Pharmaceuticals, Inc. |
| Jul 29, 2025 | 12,374,429 | Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfaces | Computer technology | Recursion Pharmaceuticals, Inc. |
| Jul 29, 2025 | 12,373,950 | Training and utilizing machine learning models to generate perturbation embeddings from phenomic images of cells, including neuronal cell images | Computer technology | Recursion Pharmaceuticals, Inc. |
| Jul 1, 2025 | 12,346,289 | Cross-platform flexible data model for dynamic storage, management, and retrieval of high-volume object data | Computer technology | Recursion Pharmaceuticals, Inc. |
| May 13, 2025 | 12,300,360 | Preemptible-based scaffold hopping | Computer technology | Recursion Pharmaceuticals, Inc. |
| Dec 17, 2024 | 12,170,135 | Systems and methods for evaluating query perturbations | Medical technology | Recursion Pharmaceuticals, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 25, 2025 | 2025/0391518 | TRAINING AND UTILIZING COMPOUND GRAPH NEURAL NETWORKS TO GENERATE BIOLOGICAL ACTIVITY PREDICTIONS FROM INPUT CHEMICAL COMPOUNDS | Computer technology | Recursion Pharmaceuticals, Inc. |
| Dec 25, 2025 | 2025/0391515 | DETERMINING PHENOMIC RELATIONSHIPS BETWEEN COMPOUNDS AND CELL PERTURBATIONS UTILIZING MACHINE LEARNING MODELS | Computer technology | Recursion Pharmaceuticals, Inc. |
| Dec 11, 2025 | 2025/0378905 | UTILIZING A CLINICAL-PHENOMICS CAUSAL DISCOVERY FRAMEWORK TO GENERATE CAUSAL DISCOVERY PREDICTIONS | Computer technology | Recursion Pharmaceuticals, Inc. · patent 12,494,266 granted from it |
| Nov 20, 2025 | 2025/0356944 | GENERATING A MECHANISM OF ACTION REPRESENTATION FROM CELL REPRESENTATION EMBEDDINGS TO PREDICT A MECHANISM OF ACTION FOR A PERTURBATION | Computer technology | Recursion Pharmaceuticals, Inc. |
| Nov 6, 2025 | 2025/0342912 | UTILIZING MACHINE LEARNING MODELS TO SYNTHESIZE PERTURBATION DATA TO GENERATE PERTURBATION HEATMAP GRAPHICAL USER INTERFACES | Computer technology | Recursion Pharmaceuticals, Inc. |
| Nov 6, 2025 | 2025/0342591 | TRAINING AND UTILIZING MACHINE LEARNING MODELS TO GENERATE PERTURBATION EMBEDDINGS FROM PHENOMIC IMAGES OF CELLS, INCLUDING NEURONAL CELL IMAGES | Computer technology | Recursion Pharmaceuticals, Inc. |
| Oct 16, 2025 | 2025/0322917 | UTILIZING FLOW MEASURES OF A GENERATIVE STOCHASTIC MODEL AND ACTION VALUES OF AN ACTION-VALUE MODEL TO GENERATE STRUCTURAL REPRESENTATIONS | Computer technology | Recursion Pharmaceuticals, Inc. |
| Aug 28, 2025 | 2025/0272607 | UTILIZING A TRACTABILITY MACHINE LEARNING MODEL TO GENERATE TRACTABILITY SCORES FOR A MULTI-DOMAIN MACHINE LEARNING MODEL FOR IMPROVED MACHINE LEARNING PREDICTIONS | Computer technology | Recursion Pharmaceuticals, Inc. |
| Aug 14, 2025 | 2025/0259705 | ACTIVE LEARNING FOR DISCOVERING PAIRWISE INTERACTIONS VIA REPRESENTATION LEARNING | Computer technology | Recursion Pharmaceuticals, Inc. |
| Jul 31, 2025 | 2025/0246009 | MULTI-MODAL PAIR MATCHING FOR A MULTI-MODAL MACHINE LEARNING MODEL LEARNING PROCESS | Computer technology | Recursion Pharmaceuticals, Inc. |
What it applied for, 2024 to 2025: Computer technology 27 · Organic fine chemistry 3 · Pharmaceuticals 3 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.